Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Licitra

Showing results (301-310 of 311) with videos related to

Pageof 32
Sort By:
Cancer Causes & Control : CCC|March 11, 2021
The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying-the head and neck cancer modelLeandro L Matos, Carlos Henrique Q Forster, Gustavo N Marta, et al.
Plos One|March 17, 2023
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancersAnnalisa Trama, Lisa Licitra, Stefano Cavalieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2026
Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck CancerSri Vemulamanda, Aditi Kothari, Loris De Cecco, et al.
The Lancet. Oncology|May 17, 2021
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trialAlexander J Stratigos, Aleksandar Sekulic, Ketty Peris, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 30, 2021
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC GroupBenjamin Lacas, Alexandra Carmel, Cécile Landais, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2014
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers InitiativeJan Bogaerts, Matthew R Sydes, Nicola Keat, et al.
The Lancet. Oncology|December 1, 2022
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemicVictor Ho-Fun Lee, Marlinda Adham, Wala Ben Kridis, et al.
Ebiomedicine|November 28, 2022
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensificationPeter Y F Zeng, Matthew J Cecchini, John W Barrett, et al.
International Forum of Allergy & Rhinology|September 30, 2025
Sinonasal Sarcomas Management: An International Consensus StatementAlessandro Vinciguerra, Francesca Caspani, Marco Valentini, et al.
The Lancet. Oncology|June 15, 2020
Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensusHisham Mehanna, John C Hardman, Jared A Shenson, et al.
Pageof 32

Showing results (301-310 of 311) with videos related to

Sort By:
Pageof 32
Cancer Causes & Control : CCC|March 11, 2021
The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying-the head and neck cancer modelLeandro L Matos, Carlos Henrique Q Forster, Gustavo N Marta, et al.
Plos One|March 17, 2023
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancersAnnalisa Trama, Lisa Licitra, Stefano Cavalieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2026
Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck CancerSri Vemulamanda, Aditi Kothari, Loris De Cecco, et al.
The Lancet. Oncology|May 17, 2021
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trialAlexander J Stratigos, Aleksandar Sekulic, Ketty Peris, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 30, 2021
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC GroupBenjamin Lacas, Alexandra Carmel, Cécile Landais, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2014
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers InitiativeJan Bogaerts, Matthew R Sydes, Nicola Keat, et al.
The Lancet. Oncology|December 1, 2022
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemicVictor Ho-Fun Lee, Marlinda Adham, Wala Ben Kridis, et al.
Ebiomedicine|November 28, 2022
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensificationPeter Y F Zeng, Matthew J Cecchini, John W Barrett, et al.
International Forum of Allergy & Rhinology|September 30, 2025
Sinonasal Sarcomas Management: An International Consensus StatementAlessandro Vinciguerra, Francesca Caspani, Marco Valentini, et al.
The Lancet. Oncology|June 15, 2020
Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensusHisham Mehanna, John C Hardman, Jared A Shenson, et al.
Pageof 32